The objective of this study was to determine the effect of a sustained propylene glycol administration to recipients of frozen/thawed in vivo derived bovine embryos. Heifers were treated with oral propylene glycol for the last 20 days before embryo transfer (n ¼ 142), and untreated as controls (n ¼ 133). Progesterone, insulin, insulin-like growth factor-I, glucose, urea and triglyceride were analysed in blood on Day 0 and Day 7 of the estrous cycle corresponding to embryo transfer. The heifers were selected as recipients when showing progesterone levels <2.0 ng/ml (Day 0) and >2.5 ng/ml (Day 7), according to corpus luteum quality on Day 7 by technicians unaware of animals treated.
Introduction
After superovulation and flushing, embryos collected from a donor female are classified as able to be frozen or transferred. Embryo transfer (ET) is a reproductive tool that allows shortening the generation interval and thus improving the annual genetic gain. At the present time, ET has become a worldwide used technique, but little progress has been achieved during the last decade, especially when pregnancy rates are considered.
Propylene glycol (PPG) is a gluconeogenic precursor largely used by oral administration against ketosis in order to increase the molar percentage of ruminal propionate in postpartum dairy cattle [1] [2] [3] . Ketosis results from energy balance deficit, which has a deleterious effects on follicular growth [4, 5] and CL activity [5] . After oral administration, a portion of PPG is metabolized to propionate [6] , but the majority of PPG escapes the rumen untransformed to be converted to glucose by the liver, primarily via the lactaldehyde pathway and subsequent oxidation to lactate [7] . Propionate is transported to the liver through the portal system, where it is transformed into pyruvate and eventually glucose via oxalacetate [1, 8, 9] . Plasma concentrations of glucose and insulin are known to increase in response to PPG [10, 11] , although the exact mechanism explaining this has not been established.
It has been suggested that propionate or intermediates of PPG metabolism may stimulate pancreatic insulin secretion [12] . Follicle recruitment [12] [13] [14] as well as follicular growth and differentiation [15] are stimulated by insulin, which exerts a beneficial influence on the subsequent embryonic development [16] . Insulin and glucose concentrations are higher in pregnant than in non-pregnant repeat breeding cows [17] , and low levels of insulin delay the first ovulation, by acting on follicular development and/or LH secretion in the early postpartum [13, 18] . Insulin stimulates the in vitro proliferation and function of granulosa [14, 19] and thecal cells [20] .
Animals receiving oral doses of PPG also show increases in insulin-like growth factor-I (IGF-I) [2, 10] . The effects of IGF-I on steroidogenesis, cell proliferation, aromatase activity, folliculogenesis, ovulation, fertilization, implantation and embryonic development has been well documented in mammals [21] and re-visited in the bovine [22] . Changes in insulin are closely related to IGF-I concentrations [23] [24] [25] . Together, insulin and IGF-I affect ovarian function and early embryo development by means of a potent stimulation of bovine granulosa cells [15, 26] , and lead thecal cells to proliferate [26] . On the contrary, with low levels of both IGF-I and insulin, the follicle does not produce adequate levels of estradiol or grow to a size able to trigger the LH surge and ovulation [4] .
A minimum amount of P4 is required to sustain reproductive functions and fertility [27] [28] [29] , and the main source of P4 in blood from non-pregnant cows is thought to be the CL. Maintenance of P4 synthesis requires insulin, which facilitates lipoprotein utilization in bovine luteal cells [30, 31] . In parallel, IGF-I stimulates P4 production by cultured bovine luteal cells [32] [33] [34] , and increased IGF-I levels associates to earlier luteal development in postpartum cows [35] . In a direct way, IGF-I stimulates CL growth and steroidogenesis [26] , and dairy cows showing reduced luteal P4 secretion [36] and anestrous [35, 37] exhibit decreased plasma IGF-I. Therefore, P4 could increase in response to insulin and IGF-I, whose concentrations in turn would be higher after a PPG drenching. Experimental treatments in cattle receiving oral PPG are usually longer than 7-14 days [2, 10, 11, 13] .
Based on the ability of IGF-I to stimulate ovarian and uterine function, methods to improve pregnancy rates by using compounds leading to increases of blood IGF-I (recombinant GH) have been proposed [38, 39] , and assayed [40, 41] , although so far without positive results.
The objective of this study was to determine the capacity of a sustained PPG administration to stimulate reproductive outcomes and pregnancy rates after transfer of frozen/ thawed in vivo derived bovine embryos. In addition, metabolic parameters judged as relevant by their capacity to influence the studied effects (i.e. P4, insulin and IGF-I) were analysed in blood together with glucose, urea and triglyceride.
Materials and methods
Experiments were carried out from November 2000 up to November 2002 within selected Holstein herds belonging to a local milk recording association. Average temperatures during the experimental period were þ12.2 8C (from October to April) and þ17.3 8C (from May to September).
Management of animals
Candidate animals were cyclic heifers aged 15-18-months old, with 350 kg of required live weight (50-60% of adult weight) and body condition score of 3-3.5 units (scale of 1-5, where 1 ¼ emaciated and 5 ¼ obese). Health status was verified clinically by general and gynaecological examination. Heifers judged to be suitable (n ¼ 286) were synchronized with two doses of a synthetic PGF 2a analogue given at 11 days apart (2 ml i.m.; Estrumate 1 , Schering-Plough, Germany). Estrus detection (Day 0; 2.5 days after the second PGF 2a analogue administration on average) was based on a three times per day monitoring of behavioural signs and serum levels of P4.
Selection of recipients
Selection of recipients was performed 9.5 days after the second PGF 2a analogue application, immediately before ET. Recipient acceptance focused on time elapsed from standing estrus (6.5-7.5 days), quality of CL and serum levels of P4 on Day 0 and Day 7. A quality score was applied to the CL of each recipient after palpation per rectum by agreement of two experienced ET technicians. Quality 1 (excellent and good) CL had a palpable, external diameter estimated to be !15 mm, firm or moderately firm consistency and good attachment; the Quality 2 (poor) CL had palpable diameter <15 mm, or the CL had a soft texture and/or acceptable attachment; the Quality 3 CL (rejected for ET) was scarcely palpable, had a very soft texture and bad attachment. Once allocated to a CL Category 1 or 2, selection of recipients for ET required Day 7 P4 serum levels >2.5 ng/ml and Day 0 P4 serum levels <2.0 ng/ml [42, 43] .
Embryo transfer
Excellent quality frozen embryos derived from in vivo superovulated high genetic merit cows and heifers, were purchased from a variety of commercial suppliers.
Embryos frozen in 10% glycerol were thawed and passed through three decreasing dilutions of glycerol with 0.3 M sucrose (Emcare 1 , Immuno-Chemical Products Ltd., Auckland, New Zealand). Embryos frozen in 10% ethylene glycol were thawed and directly transferred. Embryos were non-surgically transferred to the uterine horn ipsilateral to the ovary bearing the CL, under epidural anaesthesia (5 ml, 2% Lidhocaine chlorhydrate, Laboratorios Ovejero, Leon, Spain).
Experimental design
A farm constituted an experimental unit, where candidate heifers were managed in groups of four or six animals per replicate. The experiment was repeated 58 times in the same number of dairy herds. Half of the animals in each farm were randomly selected to receive one oral daily dose of 250 ml PPG (90% purity) in the morning of the last 20 days before the predicted ET date, while the remaining half of heifers were not treated and acted as controls. Blood samples were recovered in the morning of Day 0 and Day 7 of estrous cycle corresponding to ET, at the onset of first feed intake and prior to PPG administration. P4 was analysed in all animals used in the trial (n ¼ 275 animals; 11 heifers were discarded). Insulin, IGF-I, glucose, urea and triglyceride were investigated in all animals within 21 of the 58 farms on Day 0 (n ¼ 104 heifers), out of which 12 farms were also sampled on Day 7 (n ¼ 59 heifers).
Groups of two embryos frozen in the same cryoprotectant were assigned to be transferred within a farm/replicate, unless recipients were considered inappropriate upon selection. Embryos were derived from 46 mates (two to four embryos per mate), and the design was randomized by always transferring embryos from different mating within each replicate. One hundred and thirty-eight embryos, frozen in glycerol (n ¼ 22) or ethylene glycol (n ¼ 116), were thawed and transferred on a blind basis, irrespective of the recipient allocation to the PPG or control group. More than 90% of recipients transferred were found to be 7-7.5 days after standing estrus. Gestation was palpated per rectum between 38 and 53 days after ET and calving rates were recorded.
Blood sampling and serum analyses
Blood samples were taken early in the morning from venicoccygeal vessels puncture and serum was stored at À80 8C until analysed. Day 7 P4 was directly analysed in fresh serum within 2 h after sampling.
Serum P4 was determined by ELISA by means of Ovucheck Plasma 1 Kit (Vetoquinol Diagnostics, Spain). The test was sensitive starting from 0.5 ng/ml, and cross-reactivity from steroids other than P4 was lesser than 1%. Intra-and interassay coefficients of variation were 6 and 7%, respectively. Insulin was measured by RIA, using an immunoradiometric assay based on coated-tube separation (BioSource INS-IRMA kit; BioSource Europe, S.A. Nivelles, Belgium). The sensitivity, defined as the apparent concentration two standard deviations above the average counts at zero binding, was 0.1 mIU/ml. Cross-reactive hormones were added to a high value standard (100 mIU/ml or 4 ng/ml) and the apparent insulin response was evaluated. No cross-reaction as detected for samples.
Concentration of IGF-I was determined by RIA (sandwich type) after a pre-treatment step with acid-alcohol in order to improve the clinical performance of the kit, according to the manufacturer (SM-C-RIA-CT kit; BioSource Europe, S.A. Nivelles, Belgium). Briefly, samples of 25 ml were incubated with 500 ml of acid ethanol solution in 1.5 polypropylene tubes for 30 min. After centrifugation, supernatant was used for the RIA assay. The sensitivity of test was 3 ng/ml. Percentages of cross reaction estimated by comparison of the concentration yielding a 50% of inhibition were, respectively, 0.2 for IGF-II, <0.001 for insulin and <0.01 for growth hormone (GH) and epidermal growth factor (EGF).
Radioactivity measurements were performed using a COBRA II Auto-Gamma analyser (Hewlett Packard, USA).
Glucose, urea and triglycerides were determined by colorimetric assay in a Cobas Integra 4000 analyser (Roche, Switzerland) by using commercial kits (Boehringer Mannheim Gmbh, Germany).
Statistical analysis
The following variables have been analysed: pregnancy rates, calving rates (both expressed as frequency percentages of embryos transferred), CL quality, and blood levels of P4, glucose, insulin, IGF-I, urea and triglyceride. Statistical analysis was carried out in two steps. In a first step those effects significantly affecting the analysed variables were identified. Secondly, only fixed effects showing a significant F value were used to fit a linear model using PROC GLM of SAS [44] , to estimate least square means and their correspondent standard errors (S.E.). In addition, Duncan's multiple-range test was performed on these main-effect means. The identification of the effects affecting significantly the analysed variables was carried out by means of PROC GLM of SAS [44] , except for CL quality, pregnancy rates and calving rates. Because these variables have a categorical definition the identification of the fixed effects affecting them significantly was carried out using PROC CATMOD of SAS [44] . Regardless the procedure used to test the significance of the factors affecting the variables, treatment and farm/replicate were identified to be the only factor affecting them significantly. The other factors tested (embryo origin, cryoprotectant, technician, year and season) did show no significant effect and were excluded from subsequent analysis. In addition, data were submitted to Pearson analysis to calculate correlations.
Results
As seen in Table 1 , quality of CL, as a first choice to select recipients, and P4 levels on Day 7 were significantly higher in heifers receiving PPG, leading to a higher proportion of recipients selected for ET in this group. Pregnancy rates, as well as birth rates (Table 1) , were higher in selected recipients fed with PPG. The beneficial effects of PPG influencing pregnancy, P4 concentration and CL quality, were not dependent on season (data not shown). Quality of CL correlated to P4 levels (r ¼ À0:43; P < 0:0001), with values equally distributed between both experimental groups. The highest Day 7 P4 levels were recorded on recipients fed with PPG bearing CL Quality 1 (Table 2 ), in contrast to the similar P4 levels observed between CL Quality 1 and 2 in the controls.
Within recipients transferred (n ¼ 138), the PPG group (n ¼ 83) showed higher P4 levels on Day 0 than untreated recipients (n ¼ 55) (0:92 AE 0:10 versus 0:73 AE 0:08; P < 0:05). Recipients that became pregnant (Table 3 ) exhibited higher P4 levels on Different letters in superscript in columns express significant differences: (x, y) (P < 0:0001); (a, b) (P < 0:01); (c, d) (P < 0:03). N: numbers of heifers. Different letters in superscript within columns and rows express significant differences: (x, y, z): (P < 0:01). Different letters in superscript in columns express significant differences: (a, b) (P < 0:05); (x, y) (P < 0:01).
Day 0 and Day 7, and superior CL quality than their non-pregnant counterparts. Pregnant recipients showed higher P4 concentrations only in the PPG group. However, no significant correlations were found between Day 7 P4 and pregnancy rates.
Variations of blood parameters in coincidence with the estrual or early luteal time of the recipient estrous cycle are described in Table 4 . Cumulative (PPG þ untreated) IGF-I values at estrus (n ¼ 104) were higher than on Day 7 (n ¼ 59) (293 AE 9:7 versus 262 AE 13; P < 0:05), although evidence of PPG influence was found. Thus, IGF-I values on Day 0 in the PPG group tended to be higher than Day 7 in both PPG-treated (P < 0:09) and untreated (P < 0:06) animals (not shown in table). Cumulative (Day 0 þ Day 7) insulin values increased (P < 0:01) when heifers received PPG (20:3 AE 1:5; n ¼ 104) as opposed to controls (14:5 AE 1:6; n ¼ 59). Glucose levels showed to be cycledependent, although this effect was not obvious in animals fed with PPG. Urea was higher on Day 7 and triglyceride on Day 0, but both compounds were unaffected by the PPG treatment.
As represented in Table 5 , insulin was lower in animals untreated and non-pregnant, and remarkably higher in treated with PPG that became pregnant. As opposed, glucose values were higher in pregnant animals independently of the PPG treatment. No variations were Table 4 Influence of propylene glycol (PPG) administration on serum insulin (mIU/ml), IGF-I (ng/ml), glucose (mg/dl), urea (mM) and triglyceride (mg/dl) as dependent of cycle day (estrus: Day 0; early luteal: Day 7) in heifers treated (transferred and not transferred) Different letters in superscript in columns express significant differences: (x, y) (P < 0:02); (a, b) (P < 0:05). NP: non-pregnant; P: pregnant. Different letters in superscript in columns express significant differences: (a, b) (P < 0:05); (x, y) (P < 0:01).
recorded in IGF-I, urea and triglyceride as related to the pregnant status of the recipient (data not shown). Insulin and glucose correlated on Day 0 (þ0.57, P < 0:0001), being this relationship well represented in the control group (þ0.41, P ¼ 0:0219) but not in the PPG group. This unbalance is comparable to the IGF-I correlation with insulin on Day 0, which is twice in untreated animals (þ0.65, P < 0:0001) than in their counterparts receiving PPG (þ0.33, P ¼ 0:0132). Most parameters analysed correlated with IGF-I (Day 0 glucose: þ0.25, P ¼ 0:0345; Day 7 urea: þ0.29, P ¼ 0:0232; Day 0 triglyceride: þ0.30, P ¼ 0:0263), and the marked negative correlation for insulin and urea on Day 0 in the PPG group is in contrast with the total absence of correlation in control animals (data not shown). On Day 0, insulin negatively correlated with urea (À0.33, P ¼ 0:0139), while the correlation between glucose and triglyceride was positive (þ0.56, P < 0:0001).
Discussion
Propylene glycol treatment increased P4 levels, CL general quality and Day 60 pregnancy rates and calving rates, leading to an optimized use of recipients and being less animals required for synchronization. Although no differences in CL quality were detected between PPG and control animals selected to receive an embryo (i.e. transferred), Day 7 P4 levels were higher in the group of heifers fed with PPG and transferred.
The main source of P4 in blood from non-pregnant cows is thought to be the CL, but P4 can derive from metabolism in the liver and other organs and it is possible an adrenal release [45] . We have not precise explanation about the reason of the higher levels of P4 on Day 0, but it is a feature from our selection criteria since it occurs only in selected animals from PPG group and in pregnant animals generally. Therefore, we should think in the CL quality as a cause, but correlations between P4 on Day 0 and CL quality were inexistent in this group, so the origin of the differences remains intriguing.
Animals fed with PPG and selected for transfer showed higher P4 concentrations than controls on Day 7, in spite of CL quality was the prevalent standard of judgement for selection. These differences can be explained as animals treated with PPG and bearing Quality 1 CL showed higher P4 concentrations on Day 7. This is in contrast to controls, where comparable P4 concentrations corresponded to heifers bearing Quality 1 and 2 CL. Interestingly, CL quality explained an important part of variation in pregnancy rates at Day 60 (r ¼ À0:39) and highly correlated with P4 concentrations. However, Day 7 P4 levels from untreated animals did not explain the gain in pregnancy rates, which is opposed to observations from Remsen and Roussel [42] , but agrees with other authors [46] [47] [48] and with the presence of P4 receptor in the Day 7 bovine embryo [49] . However, unlike the untreated group, recipients fed with PPG that were pregnant had higher P4 concentrations than open recipients. Data from pregnant heifers revealed that CL quality was a useful criterion to select ET recipients as a first choice and, completed with P4 levels, represent a more efficient tool in animals treated with PPG. In contrast to our results, other authors have found that CL quality and pregnancy rates are unrelated [46, 50, 51] . On the other hand, positive correlations between CL diameter and P4 levels on Day 7 have been reported, but without affecting pregnancy rates [42, 46, 47, 50] .
Apart from increasing P4 levels and improving CL quality, metabolic factors should be considered to explain the gain in pregnancy rates due to PPG observed in the present work. In response to PPG, plasma glucose and insulin concentrations typically increase by 90 min of administration [3, 13] . More authors observed similar plasma acute modifications on insulin, IGF-I and glucose levels in animals receiving oral doses of PPG [2, 10] . According to the above reports, blood sampling within the present work was planned to record non-acute effects of PPG administration (i.e. 24 h lasting from PPG administration), as it was hypothesized that reproductive parameters we studied would be probably more dependent on sustained than short-term effects. We decided to take blood samples at estrus and at day of ET since both are two important reference times from the animal production and science point of view. In addition, the cattle were already gathered and identified, which makes implementation of this program simple. Drenching with 250 ml per day of PPG is expensive, and long-term drenching can be a very intensive labour. The doseresponse for cost-effective therapeutic treatment of heifers remains to be investigated because top dressing PPG may cause reduced feed intake. However, once highly valuable embryos are concerned, administration of PPG would improve the economical outcome for the ET industry, since not only the higher calving rate obtained, but the need to synchronize less numbers of recipients, are important factors to optimize profit.
Energy and protein intake partially controls the performance of the IGF-I system [4, 36, 52, 53] . In a variety of species, including humans and farm and laboratory animals, higher concentrations of blood IGF-I are found in young, well nourished, healthy individuals [52, 54] , whereas low blood IGF-I concentrations are a reflection of a compromised state of tissue, organ and cell function [52, [54] [55] [56] . In the present work, IGF-I varied with the day of cycle and the PPG treatment, but recipients diagnosed as open did not show concentrations of IGF-I different from pregnant recipients. No changes in IGF-I as dependent on pregnancy status of the recipient is in support of an absence of nutritional deficiency in the animals taking part in the experiments. The sustained beneficial effect of PPG on pregnancy rates and the use of heifers instead of milking cows, contribute as well to discard a nutritional influence from the use of PPG. In addition, using highly expensive embryos in selected herds is a factor contributing to a more careful management and feeding of recipient animals.
The insulin receptor mediates the growth promoting actions of IGF ligands. The insulin receptor belongs to a subfamily of receptor tyrosine kinases that include IGF-I receptor and the insulin receptor-related receptor (IRR) [57] . Insulin, IGF-I and the IRR receptors can form functional hybrids, and at least nine intracellular substrates of the insulin/IGF-I receptor kinases have been identified (reviewed by [58] ). Insulin increases glucose transport in fat and muscle cells by stimulating the translocation of the glucose transporter GLUT4 from intracellular sites to plasma membrane [58] . In parallel, in cultured cells glucose leads to an IGF-I increase [59] that regulates glucose by mobilizing glucose transporters GLUT1 [60, 61] and GLUT3 [61] . All together, these data may explain the observed tend to reduced Day 0 glucose levels in heifers treated with PPG, in coincidence with the highest insulin and IGF-I concentrations. These higher values in insulin and IGF-I probably remain as a consequence of the immediate response to the high blood glucose acutely induced by PPG [2, 3, 10, 13] . The increase in glucose levels at estrus in untreated animals, accompanied by no cycle-related changes in insulin, are in coincidence with previous findings in lactating cows [26] . However, the elevated IGF-I values we detected at estrus was reported as non-significant by Alvarez et al. [26] , probably because the high number of day Â concentration interactions compared by those authors. In the present study, insulin and glucose correlation observed at estrus in the control group but not in the PPG group suggests an altered glucose regulation by insulin due to propylene glycol.
Urea has been reported to be toxic for oocytes [53, 62] and embryos recovered from superovulated cows [63] , although cows can recover depending on the period exposure to dietary urea [63] . Anyhow, in our study urea did not change in response to PPG, since it is not dietary energy but protein which negatively correlates with plasma urea [5, 53] . In contrast to the decreased urea at estrous time we found, Alvarez et al. [26] reported a decrease in urea levels along the estrous cycle. The negative correlation observed in our study coincides with the decrease of urea in milk [64] and plasma [65] induced by insulin. In mature animals a greater concentration of urea is concomitant with greater concentration of IGF-I [26, 66, 67] , which agrees with our correlations, in particular in the group of animals receiving PPG.
Oral administration of PPG increases CL quality and serum progesterone levels, although P4 probably does not increase only at corpus luteum expenses. Upon PPG administration, a higher proportion of recipients were selected for transfer, and pregnancy and calving rates were greater, so the use of PPG can improve economical benefit in the field of ET industry. Thus factors with incidence in the reproductive circuits (i.e. progesterone, insulin and probably IGF-I) are involved in the mechanisms of PPG to improve the results of embryo transfer. Further research is being developed to find the optimal dose and administration protocol before practically used.
